Liposome@Pemafibrate (K-877) and surface peptide targeting peg2k-PECAM-1 (CD31)

Liposome@Pemafibrate (K-877) and surface peptide targeting peg2k-PECAM-1 (CD31)/Liposome loaded Pemafibrate (K-877)+surface peptide targeting peg2k-PECAM-1 (CD31) is a specific targeted peptide PECAM-1 (CD31) loaded pembrolizumab (K-877) long circulating liposome nanomaterial, which belongs to the forefront of targeted delivery for cardiovascular diseases. Currently, it is only in the laboratory research stage and has no clinical products on the market. It can be used in the research of targeted treatment of atherosclerosis, vascular endothelial injury related diseases, and drug delivery system optimization.

msds of Liposome@Pemafibrate (K-877) and surface peptide targeting peg2k-PECAM-1 (CD31)